ArticleThe international journal of cardiovascular imaging2025
Screening for cardiac involvement in patients with sarcoidosis using AIIMS algorithm.
Article in The international journal of cardiovascular imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Contemporary Diagnostics of Cardiac Sarcoidosis: The Importance of Multimodality Imaging.Diagnostics (Basel, Switzerland) · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cardiac involvement worsens the prognosis of patients with sarcoidosis. Early diagnosis and treatment of cardiac involvement may improve patient outcomes. Diagnostic algorithms are a gateway to advanced imaging. Heart Rhythm Society (HRS) screening algorithm is commonly used and comprises the presence of cardiac symptoms, electrocardiography and conventional echocardiography. In this study, we aimed to test whether the addition of global longitudinal strain and biomarkers (Troponin & NT Pro-BNP) can improve the detection rate of cardiac involvement (AIIMS screening algorithm). A total of 100 patients with biopsy-proven sarcoidosis were screened for cardiac involvement. This included cardiac symptoms, NT-Pro-BNP levels, Troponin I levels, electrocardiography, and echocardiography including global longitudinal strain (GLS). Patients who were positive for any underwent cardiac MRI or radionuclide cardiac imaging to confirm the presence of cardiac sarcoidosis. Of the 100 patients screened, 23% had cardiac symptoms, 23% had ECG changes, 16% had abnormalities on conventional echocardiography, 32% of patients had abnormal GLS, 16% and 19% of patients were positive for Troponin I and NT-Pro BNP respectively. The HRS and AIIMS screening algorithms detected cardiac involvement in 24 (24%) and 32 (32%) of patients, respectively. Among these patients, 23/24 and 30/32 were confirmed to have cardiac involvement by advanced cardiac imaging. Thus, the AIIMS screening algorithm increased detection of cardiac involvement by 30%. The proposed AIIMS screening algorithm enhances the detection of cardiac involvement in patients with sarcoidosis and should be tested in a larger study.
Indexed as
Identifiers
40445485What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.